“…[22][23][24] Platelet components are particularly vulnerable to bacterial contamination, mainly due to their storage at room temperature, which allows growth of small inocula to very high titers and limits the shelflife of these products. 12,25 For several decades, efforts have been made at multiple levels to reduce STR and fatalities from bacterially contaminated platelet transfusions, including prevention of contamination during collection and processing, 8,26 culture of platelet products 24 hours after collection, 3,27-29 point-of-issue testing, 27,30,31 as well as pathogen-reduction technologies. 32,33 Introduction of culture of platelet products in 2004 led to a decrease in gram-negative contaminants, which had accounted for one-third of contaminants and twothirds of fatalities.…”